Trials / Completed
CompletedNCT02423642
Immunomodulation Effect of Regional Citrate Anticoagulation in Acute Kidney Injury Requiring Continuous Renal Replacement Therapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to study the effect of anticoagulation in immune response with Acute Kidney Injury (AKI) undergoing Continuous Renal Replacement Therapy (CRRT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Continuous renal replacement therapy with regional citrate anticoagulation | CRRT with anticoagulant : regional citrate anticoagulation Filter : AQUAMAX™ (Edwards Lifesciences) |
| PROCEDURE | Continuous renal replacement therapy with no anticoagulation or heparin | CRRT with any anticoagulant : no anticoagulation or heparin Filter : AQUAMAX™ (Edwards Lifesciences) |
Timeline
- Start date
- 2013-07-01
- Primary completion
- 2014-11-01
- Completion
- 2014-11-01
- First posted
- 2015-04-22
- Last updated
- 2021-03-05
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT02423642. Inclusion in this directory is not an endorsement.